Showing results (21-30 of 176) with videos related to
Sort By:
Pageof 18
The Journal of Liquid Biopsy|March 3, 2025
Clinical application of liquid biopsy genomic profiling in NSCLC: Asian perspectivesMolly S C Li, Kevin K S Mok, Landon L Chan, et al.Investigational New Drugs|April 15, 2021
A phase II clinical study on the efficacy and predictive biomarker of pegylated recombinant arginase on hepatocellular carcinomaStephen L Chan, Paul N M Cheng, Angela M Liu, et al.Asia-Pacific Journal of Clinical Oncology|February 28, 2014
Economic analysis of aprepitant-containing regimen to prevent chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy in Hong KongStephen L Chan, Jason Jen, Thomas Burke, et al.Expert Opinion on Therapeutic Targets|April 26, 2015
Novel therapeutic targets and predictive markers for hepatocellular carcinomaStephen L Chan, Anthony W H Chan, Winnie YeoFuture Oncology (London, England)|August 12, 2009
Role of alpha-fetoprotein in hepatocellular carcinoma: prognostication, treatment monitoring or both?Stephen L Chan, Anthony T C Chan, Winnie YeoCancers|July 9, 2022
Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma?Choong-Kun Lee, Stephen L Chan, Hong Jae ChonCurrent Oncology Reports|March 22, 2012
Management of hepatocellular carcinoma: beyond sorafenibStephen L Chan, Tony Mok, Brigette B Y MaMolecular Carcinogenesis|March 21, 2020
Contaminated and misidentified cell lines commonly use in cancer researchSiu Tim Cheung, Stephen L Chan, Kwok Wai LoJournal of Hepatology|June 11, 2025
Attenuation of the second peak of bimodal recurrence of HBV-related HCC after curative treatment in the antiviral eraLandon L Chan, Anthony W H Chan, Terry C F Yip, et al.Current Gene Therapy|December 25, 2014
Targeting angiogenic genes as a therapeutic approach for hepatocellular carcinomaChi Hang Wong, Cesar S C Wong, Stephen L ChanPageof 18